Charts
Biopharmaceutical Companies’ Investment in R&D Remains Strong
Medical Research in the U.S. Outpaces the Rest of the World
U.S. Health Care Spending Disproportionate for Patients with Chronic Conditions
Rates of Chronic Disease Projected to Rise
Americans with Chronic Conditions
Few Americans Receiving Recommended Care
Avoidable Treatment Costs and Productivity Losses
Cancer Death Rates Down
Heart Failure Rates and Heart Attack Deaths Are Declining
How Each Health Care Dollar Is Spent
Permission to reproduce is granted if proper credit is given.
Suggested Citation: Pharmaceutical Research and Manufacturers of America, Value of Medicines: Facts and Figures 2006, (Washington, DC: PhRMA, August 2006).
back to top